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of fibrosis in patients with chronic hepatitis. To confirm and expand these results, we undertook an in vivo study to compare the 1 H-MR spectral characteristics of lipids, choline-containing compounds, and glutamineglutamate complex with the histologic features (degree of steatosis, grade of activity, and stage of fibrosis) in patients with chronic hepatitis C. Metabolites were measured at 3 T with respect to intrahepatic water content, the concentration of which remains constant as disease progresses.
Subjects and Methods Patients
Thirty patients with chronic hepatitis C (17 men, 13 women; mean age, 55 years; range, 28-71 years) were included in the study. Inclusion criteria were the presence of anti-hepatitis C virus (HCV) antibodies detected with a thirdgeneration test, detectable serum HCV RNA, and liver biopsy findings compatible with chronic hepatitis C. Patients with chronic hepatitis B, cirrhosis, or autoimmune hepatitis were excluded. Two patients had a history of drug abuse and two a history of blood transfusion. Liver biopsy was performed within 30 days before or after spectroscopic analysis. At the time of spectroscopic analysis, none of the patients had fever or evidence of other infectious diseases, inflammatory disorders, or malignancy.
A total of nine healthy volunteers who matched the enrolled patients in age and sex acted as controls. All controls had no history of liver disease, alcoholism, blood transfusion, or a positive test result for anti-HCV, anti-hepatitis B virus, or anti-HIV antibodies. All controls had a body mass index (weight in kilograms divided by height squared in meters) less than 27, cholesterol level less than 200 mg/dL, triglyceride level less than 170 mg/dL, and no evidence of fatty liver at sonography.
The study was approved by our internal committee. All patients and controls gave written informed consent. Quantification of HCV RNA in serum samples was performed with a commercially available kit (Amplicor HCV monitor TM test, Roche Diagnostic Systems). The limit of detection of the HCV RNA assay was fewer than 200 copies/mL. HCV genotype was determined for all patients with a line probe assay (Inno-LiPA HCV II, Innogenetics). Genotypes were classified according to the system of Simmonds and colleagues [21] .
Histologic Evaluation
Liver biopsy specimens longer than 10 mm were fixed in formalin, embedded in paraffin, and stained with H and E or picrosirius red for collagen and Perls' technique for iron. All biopsies were performed on the right hepatic lobe, where the sample for MR spectral acquisitions was located. For each liver biopsy specimen, stages of fibrosis and grade of histologic activity (histologic grade) were grouped according to the METAVIR classification [22] . Grades of histologic activity indicating the intensity of necroinflammatory lesions were as follows: 0, no activity; 1, mild activity; 2, moderate activity; 3, severe activity. Fibrosis was staged as follows: 0, no fibrosis; 1, portal fibrosis without septa; 2, few septa; 3, numerous septa without cirrhosis; 4, cirrhosis. Steatosis was graded as follows [23] : 0, none; 1, mild (involving < 10% of hepatocytes); 2, moderate (involving 10-30% of hepatocytes); and 3, severe (involving > 30% of hepatocytes).
MR Spectroscopy
MR spectroscopy was performed with a 3-T system (Achieva, Philips Medical Systems) by a radiologist and a clinical scientist both experienced with MR spectroscopy. A Q body coil was used for the radiofrequency-transmitting signal and a body surface coil for signal receiving. Spectra were acquired with a 90-180-180 volume-selective single-voxel point-resolved spectroscopic sequence (PRESS) (TR/TE, 1,500/38; 256 measurements; 1,024 sample points yielding an acquisition time of 6:38 minutes). Although a longer TR would minimize T1 weighting in the signal, the chosen TR was an acceptable compromise between the T1 effects and the examination time. A longer TR would have been ideal, but in our clinical setting it would have led to a longer scanning time with the consequent increasing risk of motion artifacts.
The voxel (volume of interest [VOI]) size was 30 × 30 × 40 mm. T2-weighted images were used to locate the voxel deep within the right hepatic lobe to avoid large blood vessels and the gallbladder (point 1) (Fig. 1) . To reduce to a minimum respiratory motion-induced magnetic field inhomogeneity and the consequent risk of decrease in sensitivity and precision due to accentuated linebroadening artifacts, patients were trained to perform very relaxed and calm respiration. No outer-volume suppression bands were used because the VOI was carefully located fully inside the deep hepatic parenchyma to prevent contamination by subcutaneous fat and adjacent structures. Fully automated frequency determination, power optimization, and shimming phases were performed in the VOI. Two proton MR spectra were acquired from the same VOI for every case: a water-suppressed PRESS sequence with a selective excitation pulse to crush the water signal and a water-nonsuppressed PRESS sequence without the selective excitation pulse. Because it remains stable during disease progression, water was used as an internal stable standard of reference for metabolite quantification. To assess the reproducibility of the 1 H-MR spectroscopic results, analyses were repeated in triplicate, and results were expressed as the mean of three experiments. Spectroscopy was conducted with the subject in the fasting state.
Processing of Spectral Data
Data were processed with an automatic customized script on the MRI console (Intera 3T, Philips Medical Systems) by a radiologist and a clinical scientist experienced with MR spectroscopy and blinded to the clinical patient data. The script entailed an initial baseline calculation and subtraction with a polynomial function. Metabolites to be estimated were defined with a reference database of known peaks [24] . For water-nonsuppressed acquisition, the water peak was identified and assigned a value of 4.7. For the water-suppressed signal, the metabolite peaks were assigned as 
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follows: lipid peak, 0.9-1.2 ppm; glutamateglutamine complex peak, 2.1-2.4 ppm; cholinecontaining compound peak, 3.2-3.3 ppm. A gaussian line shape was assumed for fitting of all resonances. The acquired spectra were analyzed with a Marquardt-Levenberg least squares algorithm, in which the differences between the acquired spectra are iteratively minimized and the model-based spectrum are defined a priori on the basis of the database and the gaussian constraint. After the algorithm was applied, the script displayed the estimated peak areas. Resonance areas were normalized by division of each fitted resonance of interest area value in the water-suppressed spectrum by the fitted water area value in the corresponding non suppressed water spectrum. The particular metabolite concentration was expressed in relative units according to the following pattern: meta bolite/water content = (area of metabolite × 1,000) / area of nonsuppressed water.
Statistical Analysis
Data were analyzed with the nonparametric Mann-Whitney U test. Correlations for the univariate analysis were evaluated with Spearman's non parametric test. To assess the independent value of each parameter related to cholinecontaining compounds and glutamine-glutamate complex, multiple regression analysis was performed by means of stepwise logistic re gression analysis. A value of p < 0.05 was considered significant.
On the basis of the spectroscopic findings, histologic grade and steatosis were classified with 10-fold cross-validated stepwise discriminant analysis. In stepwise discriminant analysis, a model of discrimination is built step by step. Specifically, at each step all variables are reviewed and evaluated to determine which one contributes most to the discrimination between groups. That variable is included in the model, and the process is initiated again. Performance assessment of the discriminant analysis was conducted with 10-fold crossvalidation estimation. In the 10-fold crossvalidation, the data were divided into 10 subsets (learning samples) of approximately equal size. The analysis was per formed 10 times, once for each subset, and each time one patient was left out (test sample). The test sample was in turn classified with the set of discriminant functions derived from the subset analyzed. Classification accuracy was defined as the ratio between the number of cases correctly classified and the total number of cases in the set. All statistical analyses were performed with the statistical package SPSS (version 10.0.1, SPSS) for Microsoft Windows.
Results

Patients
The clinical and histopathologic characteristics are summarized in Table 1 .
Correlation Between Water Peak Areas and Histopathologic Findings
We analyzed the correlation between the peak area of nonsuppressed water determined with 1 H-MR spectroscopy and the histopathologic characteristics among patients with hepatitis C. The hepatic content of water did not vary significantly with disease severity. As shown in Figure 2 , there was no statistically significant correlation between water content (arbitrary units) and the degree of steatosis, histologic grade, or stage of fibrosis. Thus the relative metabolite-to-water ratios were obtained by dividing the peak areas of lipid, choline-containing compounds, and glutamineglutamate complex by the peak area of water.
Correlation Between Spectroscopic Features of Lipids and Histopathologic Findings
As shown in Figure 3A , there was a strong direct correlation between 1 H-MR spectroscopically measured lipid concentration and the degree of steatosis at histologic examination (r = 0.9236; 95% CI, 0.8411-0.9641; p < 0.0001). Figure 3A also shows that measurement of hepatic lipids with 1 H-MR spectroscopy resulted in clear separation between the groups formed according to degree of histologically determined steatosis. Lipid concentration measured with 1 H-MR spectroscopy and histologic grade consistently varied together (r = 0.7265; 95% CI, 0.4875-0.8642; p < 0.0001). A significant difference in lipid resonance, however, was achieved only between patients with histologic grade 0-1 disease and patients with histologic grade 2-3 disease (Fig. 3B) . Similarly, a significant direct correlation was found between 1 H-MR spectroscopically measured lipid concentration and fibrosis score (r = 0.8156; 95% CI, 0.6382-0.9108; p < 0.0001). Again, a significant difference in lipid resonance was achieved only between patients with fibrosis scores of 0-1 and patients with fibrosis scores of 2-3 ( Fig. 3C ).
Correlation Between Spectroscopic Features of Choline-Containing Compounds and Glutamine-Glutamate Complex and Histopathologic Findings
An increase in both choline-containing compounds (r = 0.9166; 95% CI, 0.8270-0.9607; p < 0.0001) and glutamine-glutamate 
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complex (r = 0.8805; 95% CI, 0.7571-0.9432; p < 0.0001) was observed with increasing histologic grade, and statistically significant differences were found between all of the grades (Fig. 4) . Similarly, levels of both cholinecontaining compounds (r = 0.6902; 95% CI, 0.43-0.8445; p < 0.0001) and glutamineglutamate complex (r = 0.7291; 95% CI, 0.4917-0.8656; p < 0.0001) consistently varied with degree of steatosis. However, levels of these metabolites had better correlation with histologic grade scores than with degree of steatosis. No separation was achieved between steatosis scores 0 and 1 for choline-containing compounds (p > 0.05) or 0 and 1 (p > 0.05) or 2 and 3 (p > 0.05) for glutamine-glutamate complex (Fig. 5) . In contrast, concentration of neither choline-containing compounds (r = 0.3585, p > 0.05) nor glutamine-glutamate complex (r = 0.347, p > 0.05) showed any correlation with severity of fibrosis (Fig. 6) .
We performed multiple regression analysis to assess whether degree of steatosis or histologic grade made a significant contribution to levels of choline-containing compounds and glutamine-glutamate complex in one patient. As shown in Table 2 , after the effect of steatosis was accounted for, histologic grade was the only variable to significantly (p < 0.0001) affect the concentrations of choline-containing compounds and glutamine-glutamate complex. Figure 7 shows the 1 H-MR spectra of lipids, choline-containing compounds, and glutamine-glutamate complex from the livers of a control subject and of four typical patients with increasing severity of liver disease.
Histologic Grade Classification Based on Liver Metabolic Profile
The results of classification of histologic grade by means of 10-fold cross-validation stepwise discriminant analysis are shown in Table 3 and Figure 8A . The stepwise discriminant analysis was performed for choline-containing compounds, glutamine-glutamate complex, and lipid. In the first step, the variable choline-containing compounds had the highest explanatory power. In the second step, the variable glutamine-glutamate complex was com bined with cholinecontaining compounds. The variable lipid was removed from the analysis at the next step with an F value less than the chosen Fto-remove tolerance level (lipid, F = 0.65; p = 0.59). The cross-validated analysis showed that a correct diagnosis was suggested in six (75%) of eight cases for a histologic grade of 0, in seven (58%) of 12 cases for a grade of 1, in three (60%) of five cases for a grade of 2, and in five of five cases for a grade of 3. The groups with the larger relative misclassification rates were grade 1 (42%) and grade 2 (40%). Among the 12 patients with an actual grade of 1, three patients were classified as having grade 0 disease and two as having grade 2 disease. In two of the five patients with actual grade 2 disease, the disease was incorrectly classified grade 1. Cholinecontaining compounds had a larger standardized Spectroscopy of Hepatitis C canonical coefficient (0.70) compared with glutamine-glutamate complex (0.57), accounting for the greatest contribution to discrimination between groups.
Steatosis Classification Based on Liver Metabolic Profile
Results of classification of steatosis by means of 10-fold cross-validated stepwise discriminant analysis are shown in Table 4 and Figure 8B . The stepwise discriminant analysis was performed with all three of the selected variables (choline-containing compounds, glutamine-glutamate complex, and lipid). In the first step, the variable lipid had the highest explanatory power. In the second step, the variable glutamine-glutamate complex was combined with lipid. The variable cholinecontaining compounds was removed from the analysis at the next step with an F value less than the chosen F-to-remove tolerance level (choline-containing compounds, F = 2.18; p = 0.11). Cross-validated analysis showed that a correct diagnosis was suggested in nine (75%) of 12 cases for steatosis score 0, in six (66%) of nine cases for steatosis score 1, in four (80%) of five cases for steatosis score 2, and in three (75%) of four cases for steatosis score 3. The group with the larger relative misclassification rate (34%) was steatosis score 1. Among nine patients with an actual steatosis score of 1, two patients were classified as having a score of 0 and one patient as having a score of 2. Lipid played the major role in discriminating between groups, having a larger standardized canonical coefficient (0.82) than glutamine-glutamate complex (0.62).
Discussion
MR spectroscopy is a noninvasive technique that facilitates the study of cellular metabolism. It is a research tool widely used by biochemists for in vitro investigation of pathophysiologic processes and, more recently, by radiologists for in vivo detection of abnormalities. We correlated the in vivo 1 H-MR spectroscopic features of chronic hepatitis C with the histopathologic features of liver biopsy specimens. We found that intrahepatic lipid content measured with 1 H-MR spectroscopy strongly correlates with the degree of steatosis and correlates to a lesser extent with histologic grade and stage of fibrosis determined at histopathologic examination. In addition, in univariate analysis, the 1 H-MR spectroscopic signal intensities of both choline-containing compounds and glutamineglutamate complex had a direct correlation with the extent of necroinflammatory activity and steatosis but not with fibrosis stage. In multivariate analysis, the only factor independently associated with levels of choline-containing compounds and glutamine-glutamate complex was necroinflammatory activity.
Since the early 1990s, several groups have reported the utility of 1 H-MR spectroscopy in quantifying fat fraction in tissues [25, 26] . Tarasów et al. [27] performed 1 H-MR spectroscopic examinations to establish normal lipid concentrations in the livers of healthy subjects. Longo et al. [18] and Thomsen et al. [19] found a significant relation between histologic degree of steatosis and lipid content measured with 1 H-MR spectroscopy. Duarte et al. [28] , using high-resolution magic angle spinning 1 H-MR spectroscopy for the metabolic assessment of biopsy samples from human liver transplants at the donor and recipient stages, found biochemical differences between livers used for transplants that can be related to the degree and type of lipid composition. We analyzed findings on a cohort of patients with HCV infection with different degrees of steatosis, from none to severe. This stratification and the relatively large sample size assured that subject heterogeneity within groups did not bias our interpretation of the results.
Cho et al. [20] undertook an in vivo study to correlate the in vivo hepatic 1 H-MR spectroscopic features of patients with chronic hepatitis with the histopathologic stages of fibrosis. They reported a decrease in lipid peak that progressed with disease severity, which was evident in stage 4 fibrosis. The discrepancies might have been due to the fact that Cho et al. did not measure absolute lipid peaks and did not correlate the lipid MR spectroscopic measurements with the results of histologic evaluation of steatosis. Moreover, they includ- ed patients with both HCV and hepatitis B virus chronic hepatitis. We, however, did not include patients with cirrhosis, who on clinical and biochemical grounds can be accurately differentiated from subjects in whom cirrhosis has not developed.
Liver steatosis is a frequent histologic finding in patients with chronic hepatitis C, and it has been found to be an important feature of chronic hepatitis C [29, 30] . Whether steatosis is mainly related to host factors or to the virus itself is uncertain. Even when all causes are carefully excluded, a substantial proportion of patients with chronic hepatitis C still have steatosis [31] . In vitro and in vivo studies have shown that HCV core protein can induce steatosis in transfected cells [32] and transgenic mice [33] . It has also been suggested [34] that hepatic steatosis is the morphologic expression of the cytopathic effect of HCV genotype 3. The role of steatosis in the development of fibrosis in patients with chronic hepatitis C continues to be debated. Results of several studies [13] [14] [15] [16] [17] have suggested a relation between degrees of liver steatosis and of hepatic fibrosis. In light of these considerations, strict follow-up of steatosis progression in patients with chronic HCV infection, particularly those with genotype 3, is desirable. In this setting, a tool such as 1 H-MR spectroscopy, with which steatosis severity can be evaluated noninvasively, may prove helpful in the management of chronic hepatitis C, for gauging response to treatment, and for correlating the degree of hepatic steatosis with HCV replication in patients with HCV genotype 3.
Hepatosteatosis plays a pivotal pathogenetic role in the development of nonalcoholic steatohepatitis (NASH) [35] . Results of followup studies [36] [37] [38] with patients with NASH have suggested that progressive liver fibrosis and cirrhosis develop in 20-40% of these patients. Hydrogen-1 MR spectroscopy, which, as we found, is accurate in evaluation of both fatty infiltration and necroinflammatory activity, can be suggested as a follow-up examination of patients with sonographic evidence of fatty liver and normal serum enzyme levels. We also found that the amount of intrahepatic metabolites, such as choline-containing compounds and glutamine-glutamate complex, increased consistently with histologic grade but not with stage of fibrosis. Cho et al. [20] , using 1 H-MR spectroscopy, also found higher levels of these metabolites in a cohort of patients with chronic viral hepatitis than in control subjects. Unlike us, they did find a correlation between concentrations of choline-containing compounds and glutamineglutamate complex and stage of fibrosis. Cho et al., however, did not stratify patients according to histologic grade but only according to stage of fibrosis. Thus it is possible that patients with high fibrosis scores had also high histologic grade scores. Cho et al. also measured the concentrations of choline-containing compounds and glutamine-glutamate complex with respect to lipid resonance. Because the extent of hepatic steatosis is variable in patients with chronic hepatitis C, quantification of metabolites with respect to lipid resonance may produce spurious results.
Glutamine-glutamate complex is the most abundant free amino acid in the body. It is known to play a regulatory role at the gene and protein levels in several cell-specific processes, including metabolism, cell proliferation, and protein synthesis and degradation [38] . The metabolites that contribute to the cholinecontaining compound spectroscopic peak (choline, phosphocholine, and glycerophosphorylcholine) are either cell membrane precursors (choline and phosphocholine) or cell membrane degradation products (glycerophosphorylcholine) [39] . Thus the concentration of these substances in tissues is expected to increase with increasing cell turnover. During HCV infection, inflammation due to local compartmentalization of HCV-specific CD4-positive and CD8-positive T cells is responsible for hepatocyte death through apoptosis. As a consequence, the liver attempts to regenerate itself by increasing cell turnover, which is directly related to the degree of inflammation. Moreover, liver-infiltrating T cells have a high proliferation index. It therefore is not surprising that levels of both choline-containing compounds and glutamine-glutamate complex increase with increasing histologic grade. In Spectroscopy of Hepatitis C contrast, levels of neither choline-containing compounds nor glutamine-glutamate complex correlate with fibrosis stage. This phenomenon also is not surprising. Fibrosis results from collagen deposition due to activation of stellate cells [14] . Although it is triggered by inflammation and eventually correlates with it, this process may not correlate with fibrosis stage in a single biopsy assessment.
Various methods have been suggested for classification of spectra into groups. We used cross-validated discriminant analysis, a technique that has been widely used in medical science for pattern recognition [40, 41] , to assess whether the 1 H-MR spectroscopic metabolite patterns we obtained were useful for classifying individual histologic grade and steatosis groups. The results of validated analysis based on choline-containing compound, glutamine-glutamate complex, and lipid resonance were correct in classification A large relative misclassification rate (40%) was observed for histologic grade 3. However, the incorrect predictions (two patients with grade 2 mistaken for grade 1) were associated, respectively, with posterior probabilities of 0.521 and 0.513, whereas the posterior probabilities of grade 2 were, respectively, 0.479 and 0.487. Thus in these two cases, the results of analysis would have been predictive of the correct classifications if a reasonable threshold for posterior probability had been set. A large misclassification rate also was observed for group 1 of both the histologic grade (42%) and steatosis (34%) classifications, both having an associated posterior probability greater than 0.60 (mean, 0.65 ± 0.4). This result might have been due to the inherent inaccuracy in the standard criterion used for establishing the final diagnosis.
Siddique et al. [42] observed in a cohort of 29 patients with chronic hepatitis C that 44.8% of the subjects had a difference of one or more grades between two biopsy samples from the right lobe. The most commonly observed cause of intrapathologist and interpathologist disagreement is heterogeneous space distribution of disease, such as that observed in the early stages of disease [5, 6] .
MR spectroscopy is not strictly operator dependent and offers the possibility of performing multiple measurements, reducing intraexamination and interexamination variability. Because the whole sample of tissue included in the VOI is evaluated with MR spectroscopy and the mean spectrum for the entire sample is acquired, a more accurate picture of diffuse hepatic disease is obtained than with histologic characterization of a small tissue sample. In our study, the 10-fold cross-validation method was used to evaluate classification performance. This analysis is generally used when no test sample is available and when the learning sample is too small to have the test sample taken from it, as in our case. To obtain consistent comparative values in our data set, we accepted lower capability to extrapolate our results to as yet unknown data sets.
Although 1 H-MR spectroscopy cannot be used for evaluation of hepatic fibrosis, our data suggest that this technique is a possible alternative to liver biopsy in the evaluation of steatosis and necroinflammatory activity in diffuse liver disease. 
